PEPTIDES 2017* Lirong Hu
China Pharmaceutical University, CHINA, China
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
An integrin αvβ3 antagonistic modified peptide inhibits tumor growth through inhibition of the ERK and AKT signaling pathways (#94)
8:00 PM
Lirong Hu
Poster Session 1